News
Mittwoch, 09.02.2022
Study guide and review Diseases of the Oral Mucosa
Schmidt E. (Ed.), Springer, 2021 | https://link.springer.com/978-3-030-82804-2
- Details the latest diagnosis and management options...
Montag, 01.11.2021
Comprehensive review article on "Lichen planus" published
Boch et al, Lichen planus. Front. Med., 01 November 2021 | https://doi.org/10.3389/fmed.2021.737813
Abstract:
Lichen planus (LP) is a T cell-mediated...
Montag, 03.05.2021
Risk of COVID-19 in pemphigus and pemphigoid
The risk of COVID-19 in patients with bullous pemphigoid and pemphigus: A population-based cohort study
Kridin et al, J Am Acad Dermatol. 2021 Mar...
Mittwoch, 17.03.2021
A Mitochondrial Polymorphism Alters Immune Cell Metabolism and Protects Mice from Skin Inflammation
Abstract:
Several genetic variants in the mitochondrial genome (mtDNA), including ancient polymorphisms, are associated with chronic inflammatory conditions, but investigating the functional consequences of such mtDNA polymorphisms in humans is challenging due to the influence of many...
Mittwoch, 17.03.2021
Milestones in Personalized Medicine in Pemphigus and Pemphigoid
New paper in Front Immunol.
Abstract:
Pemphigus and pemphigoid diseases are autoimmune bullous diseases characterized and caused by autoantibodies targeting adhesion molecules in the skin and/or mucous membranes. Personalized medicine is a new medical model that separates...
Mittwoch, 17.03.2021
A History of Asthma Increases the Risk of Bullous Pemphigoid: Insights from a Large Population-Based Study
Abstract:
Background: Bullous pemphigoid (BP) and asthma both share a pathogenic role of eosinophils and immunoglobulin E (IgE) and favorable response for corticosteroids and omalizumab. However, the association between these conditions is yet to be...
Mittwoch, 17.03.2021
Estimating the Odds of Ulcerative Colitis-Associated Pyoderma Gangrenosum: A Population-Based Case-Control Study
New paper by LIED researcher in Dermatology
Abstract:
Background: Ulcerative colitis (UC) is a well-known underlying comorbidity of pyoderma gangrenosum (PG). However, the risk conferred by UC for the subsequent development of PG is yet to be...
